When the promise of COVID-19 vaccines was teased a few months into the pandemic, skepticism abounded. Members of the scientific community soberly noted that an accelerated vaccine development timeline might reasonably be set at 18 months, while anti-vaxxers loudly relitigated their concerns about safety, eficacy and government invasion of privacy. What we know now, of course, is that the vaccines are miracles of science — and, at least through late February, people can’t get enough of them. So, in advance of an anticipated reversal within the next two months — where vaccine supply crests and demand wanes — the Centers for Disease Control and Prevention examined vaccination intent at two different moments: In September 2020, when the Pfizer/BioNTech, Moderna and Johnson & Johnson vaccines were but a dim dot on the horizon; and in mid- December 2020, when shots first started going into arms. What it found were pockets of doubt and mistrust, sure, but also movement toward acceptance. Hey, it’s a start.

Source: The Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report, “COVID-19 Vaccination Intent, Perceptions and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination,” Feb. 9, 2021; September data are from IPSOS KnowledgePanel Survey, fielded Sept. 3-Oct. 1, 2020 (3,541 respondents). December data are from IPSOS KnowledgePanel Omnibus Survey, fielded Dec. 18-Dec. 20, 2020 (1,005 respondents).